Medizalbu is a Human Albumin 20 Injection formulated to restore and maintain plasma volume in patients suffering from hypoalbuminemia, shock, severe burns, liver disease, and other critical medical conditions. Human albumin is a naturally occurring plasma protein that helps maintain oncotic pressure and transports essential substances throughout the body.
Medizalbu is manufactured under stringent quality standards, making it a reliable choice for hospitals, healthcare institutions, and pharmaceutical distributors seeking a high-quality Human Albumin 20% Injection.
Human Albumin 20 Injection is a sterile intravenous solution containing 20% human albumin protein derived from screened human plasma. It is used to restore blood volume, improve circulatory function, and treat conditions associated with low serum albumin levels.
Medizalbu is intended for administration by qualified healthcare professionals in hospital and clinical settings.
Helps restore plasma volume effectively.
Supports treatment of hypoalbuminemia.
Maintains colloid osmotic pressure.
Assists in managing severe burns and trauma.
Used in liver cirrhosis and ascites management.
Supports critically ill and ICU patients.
High-quality manufacturing with strict quality control.
Reliable product for hospitals and institutional procurement.
Medizalbu Human Albumin 20 Injection is commonly prescribed for:
Hypoalbuminemia
Liver cirrhosis with ascites
Severe burns
Septic shock
Major surgery
Trauma management
Plasma volume replacement
Critical care and intensive care units (ICU)
Therapeutic plasma exchange
Fluid resuscitation under medical supervision
Human albumin is the primary protein responsible for maintaining plasma oncotic pressure. When albumin levels fall, fluid leaks from blood vessels into surrounding tissues, leading to edema and reduced blood volume.
Medizalbu Human Albumin 20 Injection restores circulating albumin levels, helping to:
Increase plasma volume
Improve circulation
Reduce tissue swelling
Enhance tissue perfusion
Support overall hemodynamic stability
The dosage of Human Albumin 20 Injection varies according to:
Patient's body weight
Clinical condition
Albumin deficiency
Fluid balance
Laboratory parameters
The injection should only be administered intravenously by qualified healthcare professionals. Dosage and infusion rate must be determined by the treating physician.
Like all medicines, Human Albumin 20 Injection may cause side effects in some patients.
Possible side effects include:
Fever
Chills
Nausea
Flushing
Headache
Allergic reactions
Changes in blood pressure
Rare hypersensitivity reactions
Immediate medical attention is required if severe allergic symptoms occur.
Before administration, healthcare providers should evaluate:
History of allergy to human albumin
Heart failure
Severe anemia
Kidney impairment
Hypervolemia
Pulmonary edema
Continuous monitoring during infusion is recommended.
Medizalbu is trusted by healthcare professionals for its quality, safety, and consistent performance.
Premium Human Albumin 20 Injection
Manufactured under stringent quality standards
Suitable for hospital and institutional use
Reliable supply chain
Bulk supply available
Third-party manufacturing support
Contract manufacturing services
Distribution opportunities across India and international markets
Medizalbu Human Albumin 20 Injection is widely used in:
Intensive Care Units (ICU)
Emergency departments
Multispecialty hospitals
Liver care centers
Trauma centers
Burn units
Surgical departments
Critical care facilities
Store according to the product label and applicable regulatory guidelines.
Protect from excessive heat and freezing.
Keep out of the reach of children.
Use only if the container and solution are intact.
It is used to restore plasma volume and treat hypoalbuminemia, liver disease, burns, shock, and other conditions requiring albumin replacement.
No. It should only be administered intravenously by trained healthcare professionals.
Yes. Medizalbu is intended for hospital and institutional use under medical supervision.
Hospitals, government institutions, pharmaceutical distributors, healthcare procurement agencies, and authorized wholesalers can procure Medizalbu through approved supply channels.
Medizalbu Human Albumin 20 Injection is a dependable plasma protein replacement therapy designed for patients requiring effective albumin supplementation. With its role in maintaining plasma volume and supporting critical care management, Medizalbu is an important therapeutic option for hospitals and healthcare providers. Its consistent quality, reliable supply, and suitability for institutional procurement make it an excellent choice for healthcare organizations seeking a trusted Human Albumin 20 Injection.